01-08-2017 | PHASE I STUDIES
Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II
Published in: Investigational New Drugs | Issue 4/2017
Login to get access01-08-2017 | PHASE I STUDIES
Published in: Investigational New Drugs | Issue 4/2017
Login to get access